What are the possible causes of elevated albumin, red blood cell count, hematocrit, and hemoglobin, and what further testing is indicated?

Elevated Albumin, RBC, Hematocrit, and Hemoglobin: Causes and Workup

The simultaneous elevation of albumin, RBC count, hematocrit, and hemoglobin most commonly indicates hemoconcentration from volume depletion, but you must urgently rule out polycythemia vera (PV), which carries significant thrombotic risk and mortality if untreated.

Primary Differential Diagnosis

The constellation of elevated albumin alongside elevated hemoglobin, hematocrit, and RBC count points to two main categories:

1. Hemoconcentration (Most Common)

• Dehydration/volume depletion causes relative increases in all cellular and protein components
• Albumin elevation is the key distinguishing feature—true polycythemia does NOT elevate albumin
• Look for: recent fluid losses (vomiting, diarrhea, diuretics, poor intake), orthostatic vital signs, elevated BUN/creatinine ratio, concentrated urine

2. Polycythemia Vera (Must Rule Out)

• Critical distinction: PV causes true RBC mass increase but albumin remains normal or low
• If albumin is truly elevated alongside RBC parameters, this suggests concurrent hemoconcentration masking an underlying myeloproliferative disorder
• PV diagnostic criteria per WHO 2016 1:
  • Hemoglobin >16.5 g/dL (men) or >16 g/dL (women)
  • Hematocrit >49% (men) or >48% (women)
  • Requires JAK2 mutation testing plus bone marrow evaluation

Algorithmic Approach to Further Testing

Step 1: Assess Volume Status (Immediate)

• Repeat CBC and albumin after adequate hydration
• If values normalize → diagnosis is hemoconcentration, no further workup needed
• If RBC parameters remain elevated but albumin normalizes → proceed to Step 2

Step 2: JAK2 Mutation Testing (Priority)

The 2018 European LeukemiaNet guidelines emphasize JAK2 mutation as a major diagnostic criterion 1. Order:

• JAK2 V617F mutation (present in >97% of PV cases) 2
• If negative, test for JAK2 exon 12 mutations

Step 3: Erythropoietin Level

• Subnormal serum erythropoietin is a minor criterion for PV diagnosis 1
• Low EPO with elevated RBC parameters strongly suggests primary polycythemia
• Normal/high EPO suggests secondary causes (see below)

Step 4: If JAK2 Positive or EPO Low

Proceed with:

• Bone marrow biopsy showing hypercellularity with trilineage myeloproliferation 1
• Screen for thrombotic complications (history of DVT, stroke, MI)
• Baseline abdominal ultrasound (splenomegaly present in many cases)

Step 5: If JAK2 Negative and EPO Normal/High

Evaluate for secondary erythrocytosis:

• Arterial oxygen saturation (chronic hypoxia from lung disease, sleep apnea, high altitude)
• Carboxyhemoglobin level (smoking)
• Renal ultrasound (renal cell carcinoma, polycystic kidney disease causing inappropriate EPO)
• Hepatocellular carcinoma screening if risk factors present

Critical Pitfalls to Avoid

Iron deficiency masks PV: Hemoglobin may be falsely normal in iron-deficient PV patients 2. Check:

• Ferritin, iron studies
• If iron deficient, recheck hemoglobin/hematocrit after iron replacement before excluding PV

Don't dismiss borderline elevations: The 2007 WHO revision recognizes that sustained hemoglobin increases >2 g/dL above baseline, even without reaching absolute thresholds, warrant PV evaluation 2

Albumin elevation is transient: Unlike true polycythemia, hemoconcentration resolves with hydration. Persistent RBC elevation after rehydration demands myeloproliferative workup.

Risk Stratification if PV Confirmed

PV carries substantial thrombotic risk affecting mortality:

• Age >60 years or prior thrombosis = high risk
• Requires cytoreductive therapy (hydroxyurea or ruxolitinib) plus aspirin 1
• Target hematocrit <45% to reduce thrombotic events

The key clinical decision point is whether RBC parameters normalize with hydration—if not, JAK2 testing is mandatory to identify PV before life-threatening thrombotic complications occur.